Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

COVID-19 linked to rise in Drug-Resistant bacteria in ICUs

NCT ID NCT04378842

First seen May 01, 2026 · Last updated May 23, 2026 · Updated 3 times

Summary

This study examined whether being infected with SARS-CoV-2 (the virus that causes COVID-19) increases the chance of intensive care unit (ICU) patients acquiring multidrug-resistant bacteria. Researchers tracked 368 critically ill adults to see how many developed these hard-to-treat infections. The goal was to understand the impact of COVID-19 on superbug spread in hospitals, which can help improve infection control practices.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CRITICAL ILLNESS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • CH LENS

    Lens, France

  • Ch Bethune

    Béthune, France

  • Chu Amiens Picardie

    Amiens, France

  • Grand Hopital de L'Est Francilien

    Jossigny, France

  • Hospices Civils de Lyon

    Lyon, France

  • Hospices Civils de Lyon (Pierre Bénite,Edouard Herriot, La Croix Rousse)

    Lyon, France

  • Hôpital Roger Salengro, ICU, CHU Lille

    Lille, 59037, France

Conditions

Explore the condition pages connected to this study.